This resulted in the FDA holding a two-day hearing to re-evaluate its rule on mercury fillings in December 2010. There, FDA's own hand-picked panel of scientists – including neurologists, toxicologists, epidemiologists, and environmental health specialists – told the agency to stop amalgam use in children, pregnant women, and hypersensitive populations.
Panelist after panelist laid out their concerns: Dr. Kotagal said there is "no place for mercury in children"... Dr. Ismail said "in children less than six years of age, I would restrict it significantly"... Dr. Thompson said "definitely not in pregnant women and definitely not in those below six years of age"...
Dr. Fleming said we need contraindications for pregnant women... Dr. Burbacher said, "why put amalgams in children if we know they're going to live with that for the rest of their lives? And we don't know what that's going to do."
Not a single panelist agreed with FDA's 2009 rule that permitted unrestricted amalgam use in children and pregnant women. FDA has heard that message before. In 2006 its scientific advisory panel concluded – by a 13 to 7 vote – that amalgam is not generally safe for all. And now that FDA was hearing it a second time, presiding FDA official Anthony Watson announced the FDA would act quickly in response to concerns raised by the panel. Instead, the FDA failed to do anything at all.